These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10904599)

  • 1. [Early detection of colorectal carcinoma. Are you aware of the screening intervals?].
    Pox C; Schmiegel W
    MMW Fortschr Med; 1999 Sep; 141(36):45-6. PubMed ID: 10904599
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early detection of colorectal carcinoma. Pros and cons].
    von Betzler M
    MMW Fortschr Med; 2005 Apr; 147(14):26-8. PubMed ID: 15887679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening colonoscopy for early detection of intestinal cancer].
    Mader U
    Dtsch Med Wochenschr; 2003 Mar; 128(12):596. PubMed ID: 12685432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Patient information. Colorectal cancer].
    MMW Fortschr Med; 2007 Jun; 149(23):39-40. PubMed ID: 18062577
    [No Abstract]   [Full Text] [Related]  

  • 5. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of colorectal cancer at an asymptomatic stage by screening is useful.
    Komuta K; Furui J; Haraguchi M; Kanematsu T
    Hepatogastroenterology; 2000; 47(34):1011-4. PubMed ID: 11020866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical inquiries. At what age do patients no longer need colorectal cancer screening?
    Tatum P; Mehr D; Easton B
    J Fam Pract; 2001 Jul; 50(7):575-6. PubMed ID: 11485702
    [No Abstract]   [Full Text] [Related]  

  • 11. Colorectal cancer screening in the Czech Republic.
    Zavoral M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S29-30. PubMed ID: 18368637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Periodic physical examination: 1989 update. Early detection of colorectal cancer].
    Goldbloom R; Battista RN; Haggerty J
    Union Med Can; 1989; 118(6):242, 245-8. PubMed ID: 2603254
    [No Abstract]   [Full Text] [Related]  

  • 13. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based prevention of colorectal carcinoma].
    Birkner BR
    Dtsch Med Wochenschr; 2003 Dec; 128(49):2598-603. PubMed ID: 14655077
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection and prevention of colorectal cancer].
    Moubayed H; Popescu R; Aellen S; Givel JC; Michetti P; Dorta G
    Rev Med Suisse Romande; 2002 Sep; 122(9):413-6. PubMed ID: 12422468
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with screening for colorectal cancer in a population-based sample.
    Stamatakis KA; Simoes EJ; Brownson RC; Vradenburg J; Murayi T
    Mo Med; 2002 Jul; 99(7):279-85. PubMed ID: 12198998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.